1. Department of Hematology, Institut Paoli Calmettes, SIRIC-Marseille, Marseille, France;
2. Aix-Marseille University, Marseille, France;
3. Internal Medicine Department, Section of Hematology, Yale Cancer Center at Yale University, New Haven, CT, USA;
4. Department of Medical Pharmacology, CIC 1436, Université Toulouse Hospital, Inserm, Toulouse, France;
5. Department of Oncology Research and Development, Institut de Recherches Internationales Servier, Suresnes, France;
6. Biometrics, Pharmacyclics, LLC, an AbbVie Company, Sunnyvale, CA, USA;
7. Department of Clinical Science, Pharmacyclics, LLC, an AbbVie Company, Sunnyvale, CA, USA;
8. Service d’Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France;
9. Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294-CNRS, Toulouse, France